Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EPA's pleiotropic mechanisms of action: a narrative review.
Nelson JR, Budoff MJ, Wani OR, Le V, Patel DK, Nelson A, Nemiroff RL. Nelson JR, et al. Among authors: budoff mj. Postgrad Med. 2021 Aug;133(6):651-664. doi: 10.1080/00325481.2021.1921491. Epub 2021 May 13. Postgrad Med. 2021. PMID: 33900135 Review.
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.
Budoff MJ, Muhlestein JB, Bhatt DL, Le Pa VT, May HT, Shaikh K, Shekar C, Kinninger A, Lakshmanan S, Roy SK, Tayek J, Nelson JR. Budoff MJ, et al. Cardiovasc Res. 2021 Mar 21;117(4):1070-1077. doi: 10.1093/cvr/cvaa184. Cardiovasc Res. 2021. PMID: 32609331 Clinical Trial.
Association of high-density lipoprotein levels with baseline coronary plaque volumes by coronary CTA in the EVAPORATE trial.
Lakshmanan S, Shekar C, Kinninger A, Dahal S, Onuegbu A, Cai AN, Hamal S, Birudaraju D, Cherukuri L, Flores F, Dailing C, Roy SK, Bhatt DL, Nelson JR, Budoff MJ. Lakshmanan S, et al. Among authors: budoff mj. Atherosclerosis. 2020 Jul;305:34-41. doi: 10.1016/j.atherosclerosis.2020.05.014. Epub 2020 Jun 16. Atherosclerosis. 2020. PMID: 32615321
Letter by Lakshmanan et al Regarding Article "Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy".
Lakshmanan S, Budoff MJ, Nelson JR. Lakshmanan S, et al. Among authors: budoff mj. Circulation. 2022 Nov 15;146(20):e284-e285. doi: 10.1161/CIRCULATIONAHA.122.061986. Epub 2022 Nov 14. Circulation. 2022. PMID: 36374969 No abstract available.
Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses.
Peterson BE, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Tardif JC, Verma S, Ballantyne CM; REDUCE-IT Investigators. Peterson BE, et al. Among authors: budoff mj. Circulation. 2021 Jan 5;143(1):33-44. doi: 10.1161/CIRCULATIONAHA.120.050276. Epub 2020 Nov 5. Circulation. 2021. PMID: 33148016 Free PMC article. Clinical Trial.
1,173 results